公开(公告)号：USD977510S1

公开(公告)日：2023-02-07

申请号：US29773969

申请日：2021-03-12

Applicant: Abbott Laboratories

Designer： Rahul Avasthy ,  Christopher Gorz ,  Olga Androsik

公开(公告)号：USD976949S1

公开(公告)日：2023-01-31

申请号：US29746589

申请日：2020-08-14

Applicant: Abbott Laboratories

Designer： Rahul Avasthy ,  Christopher Gorz ,  Olya Androsik

公开(公告)号：US20220395542A1

公开(公告)日：2022-12-15

申请号：US17776792

申请日：2020-11-19

Applicant: ABBOTT LABORATORIES

Inventor： Enrique VÁZQUEZ HERNÁNDEZ ,  Rachael BUCK ,  JoMay CHOW ,  Karen GOEHRING

IPC: A61K35/745 ,  A61K31/702 ,  A61K47/36 ,  A61K35/747 ,  A61K35/744 ,  A61K35/741 ,  A61K36/064 ,  A61P31/04

Abstract: A nutritional composition comprises fucosylated human milk oligosaccharide and/or sialylated human milk oligosaccha-ride, non-digestible, fermentable polysaccharide, and Bifidobacterium. The nutritional composition is free of short-chain fructooligosac-charide having at least about 50% of molecules with a degree of polymerization of less than about 5. A method of treating a subject at risk of developing a Clostridium difficile infection or a subject having a Clostridium difficile infection comprises administering such a nutritional composition.

公开(公告)号：US11524018B2

公开(公告)日：2022-12-13

申请号：US15818374

申请日：2017-11-20

Applicant: ABBOTT LABORATORIES

Inventor： Rachael Buck ,  Geralyn O. Duska-McEwen ,  Joseph P. Schaller

IPC: A61K31/702 ,  A23L33/00 ,  A23L33/12 ,  A61K31/202 ,  A61K31/7016 ,  A61K45/06

Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US11514737B2

公开(公告)日：2022-11-29

申请号：US17208754

申请日：2021-03-22

Applicant: Abbott Laboratories

Inventor： Nitesh Luthra ,  Lev F. Frayman ,  Terry Finch ,  John Schullian ,  Douglas Wager ,  Nicholas Alexander Robertson Wood

IPC: G07C9/22 ,  G16H40/63 ,  G06K7/14 ,  G06K19/06 ,  G16H10/40 ,  G16H15/00 ,  G16H50/80 ,  G16H10/65 ,  G07C9/25 ,  G07C9/29 ,  G06Q50/26 ,  G16H40/20

Abstract: Digital pass verification systems and methods are disclosed herein. An apparatus disclosed herein includes memory including instructions that, when executed, cause processor circuitry to: access a result of a diagnostic test associated with a test kit identification; associate the result of the diagnostic test with a user identification; and transmit the result of the diagnostic test and the test kit identification to a first device to cause the first device to generate a machine-readable pass on a display of the first device.

公开(公告)号：US20220346429A1

公开(公告)日：2022-11-03

申请号：US17853515

申请日：2022-06-29

Applicant: ABBOTT LABORATORIES

Inventor： TAPAS DAS ,  MUSTAFA VURMA ,  CHRON-SI LAI ,  PAUL JOHNS

IPC: A23L33/00 ,  A61K38/01 ,  A23L33/12 ,  A23L33/19 ,  A23L33/18 ,  A23L33/115 ,  A61K45/06 ,  A23L29/00 ,  A61P25/28

Abstract: Disclosed embodiments provide nutritional compositions and methods of enhancing maturation of an infant's brain. The methods include the step of administering to the infant a nutritional composition comprising a protein with a degree of hydrolysis of 10% to 75% in combination with at least one of a monoglyceride, a free fatty acid, a salt of a free fatty acid, a phospholipid, and cholesterol.

公开(公告)号：US11428694B2

公开(公告)日：2022-08-30

申请号：US17231782

申请日：2021-04-15

Applicant: Abbott Laboratories

Inventor： Robert Ziemann ,  April Ahlberg ,  David Hawksworth ,  Bryan Tieman ,  A. Scott Muerhoff ,  Christopher Marohnic ,  Kathy Otis

IPC: G01N33/576 ,  C07K16/00 ,  C07K16/10

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

公开(公告)号：USD955245S1

公开(公告)日：2022-06-21

申请号：US29716123

申请日：2019-12-06

Applicant: Abbott Laboratories

Designer： Christina A. Barton ,  Sherry Sue Eckholm ,  Vladlena Belozerova ,  Ami Marie Verhalen ,  Jesse Charles Darley

公开(公告)号：US11307141B2

公开(公告)日：2022-04-19

申请号：US16237098

申请日：2018-12-31

Applicant: Abbott Laboratories

Inventor： Qiaoqiao Ruan ,  Sylvia C. Saldana ,  Joseph P. Skinner ,  Sergey Y. Tetin

IPC: G01N21/64 ,  G01N33/543

Abstract: A method for analyzing the results of a ligand-receptor binding assay comprising the steps of: (a) providing the results of a ligand-receptor binding assay; and (b) qualifying the results of a ligand-receptor binding assay. More particularly, the ligand-receptor binding assay involves the steps of combining appropriate reagents in which receptors attached to a solid support, a sample suspected of containing a ligand, and a conjugate comprising a label form a complex in which the label is present at a concentration that is directly proportional to the amount of ligand present in the sample. Alternatively, the ligand-receptor binding assay involves the steps of combining appropriate reagents to perform a ligand-receptor binding assay in which receptors attached to a solid support, a sample suspected of containing a ligand, and a conjugate comprising a label form a complex in which the label is present at a concentration that is inversely proportional to the amount of analyte present in the sample.

公开(公告)号：US20220096524A1

公开(公告)日：2022-03-31

申请号：US17298194

申请日：2019-11-27

Applicant: ABBOTT LABORATORIES

Inventor： JOSÉ MARÍA LÓPEZ PEDROSA ,  RICARDO RUEDA CABRERA ,  MANUEL MANZANO MARTÍN ,  JORGE GARCÍA MARTINEZ ,  MARÍA CAMPRUBÍ ROBLES ,  PILAR BUENO VARGAS ,  JOSEPH WALTON ,  VIKKIE MUSTAD

IPC: A61K31/718 ,  A61K31/702 ,  A61K31/7016 ,  A61K31/7004 ,  A61K31/733 ,  A61P3/02 ,  A23L33/125 ,  A23L33/00

Abstract: A method of promoting healthy catch-up growth in a moderately malnourished individual is provided. The method includes administering to the moderately malnourished individual a nutritional composition that contains a carbohydrate blend, wherein the carbohydrate blend comprises a source of at least one carbohydrate that provides rapidly available glucose, a source of at least one carbohydrate that provides slowly available glucose, and a source of at least one non-digestible carbohydrate or resistant starch.